Reserpine And Hydroflumethiazide

   
Google
 
Web NewDrugInformation.com

Reserpine And Hydroflumethiazide


Drug - Reserpine And Hydroflumethiazide
The trade name of the product as shown on the labeling.

Dosage - TABLET; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Hydroflumethiazide; Reserpine
Multiple ingredients are in alphabetical order.

Strength - 50MG;0.125MG
The potency of the active ingredient(s), Hydroflumethiazide; Reserpine. May repeat for multiple part products.

Applicant - PAR PHARM
The firm name holding legal responsibility for Reserpine And Hydroflumethiazide. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 088907
The FDA assigned number to Reserpine And Hydroflumethiazide. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Reserpine And Hydroflumethiazide. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Sep 20, 1985
The date Reserpine And Hydroflumethiazide was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Reserpine And Hydroflumethiazide. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - DISCN
The group or category of approved drugs Reserpine And Hydroflumethiazide is in. Format is RX, OTC, DISCN.

Applicant Full Name - Par Pharmaceutical Inc
The full name of the firm holding legal responsibility for the new application of Reserpine And Hydroflumethiazide.

Reserpine And Hydroflumethiazide